Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening
Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening in the Community
Sponsor: National Cancer Institute (NCI)
This observational or N/A phase trial investigates Cervical Carcinoma and Human Papillomavirus-Related Carcinoma and is currently actively recruiting participants. National Cancer Institute (NCI) leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
May 2025 — Present [monthly]
Recruiting
-
Sep 2024 — May 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2024 — Jul 2024 [monthly]
Recruiting
-
May 2023 — May 2024 [monthly]
Recruiting
▶ Show 3 earlier versions
-
May 2022 — May 2023 [monthly]
Recruiting
-
Dec 2021 — May 2022 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .